Journal of Pediatric Health Care
Volume 23, Issue 1, Supplement , Pages S5-S21 , January 2009

Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Closing Diagnostic, Communication, and Treatment Gaps

References 

  1. ADDitude Editors. (2006a, August/September). Accommodations for ADHD students: A parent's guide. Attitude. Retrieved October 16, 2008, from http://www.additudemag.com/adhd/article/749-2.html
  2. ADDitude Editors. (2006b, August/September). Know your child's educational rights. Attitude. Retrieved October 16, 2008, from http://www.additudemag.com/adhd/article/1623.html
  3. American Academy of Pediatrics. (2008). Caring for children with ADHD: A resource toolkit for clinicians. Retrieved October 16, 2008, from http://www.aap.org/pubserv/adhdtoolkit/
  4. American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement . Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108:1033–1044
  5. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed., text revision. Arlington, VA: Author; 2000;
  6. Arcia E, Fernández MC, Jáquez M. Latina mothers' stances on stimulant medication: Complexity, conflict, and compromise. Journal of Developmental and Behavioral Pediatrics. 2004;25:311–317
  7. Armstrong MB, Nettleton SK. Attention deficit hyperactivity disorder and preschool children. Seminars in Speech and Language. 2004;25:225–232
  8. Attention Deficit Disorder Association. (1998). Fact sheet on attention deficit hyperactivity disorder (ADHD/ADD). Retrieved October 16, 2008, from http://www.add.org/articles/factsheet.html.
  9. Bailey RK, Owens DL. Overcoming challenges in the diagnosis and treatment of attention-deficit/hyperactivity disorder in African Americans. Journal of the National Medical Association. 2005;97(Suppl.):5S–10S
  10. Barkley RA. Taking charge of ADHD: The complete authoritative guide for parents. New York: Guilford Press; 2000;
  11. Barlow J, Stewart-Brown S. Behavior problems and group-based parent education programs. Journal of Developmental and Behavioral Pediatrics. 2000;21:356–370
  12. Biederman J, Faraone SV. The effects of attention-deficit/hyperactivity disorder on employment and household income. Medscape General Medicine. 2006;8:12
  13. Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Silva JM, et al. Young adult outcome of attention deficit hyperactivity disorder: A controlled 10-year follow-up study. Psychological Medicine. 2006;36:167–179
  14. Bishop DV. Curing dyslexia and attention-deficit hyperactivity disorder by training motor co-ordination: Miracle or myth?. Journal of Paediatrics and Child Health. 2007;43:653–655
  15. Brown RT, Pacini JN. Perceived family functioning, marital status, and depression in parents of boys with attention deficit disorder. Journal of Learning Disabilities. 1989;22:581–587
  16. Bussing R, Zima BT, Gary FA, Garvan CW. Barriers to detection, help-seeking, and service use for children with ADHD symptoms. Journal of Behavioral Health Services and Research. 2003;30:176–189
  17. Chronis AM, Chacko A, Fabiano GA, Wymbs BT, Pelham WE. Enhancements to the behavioral parent training paradigm for families of children with ADHD: Review and future directions. Clinical Child and Family Psychology Review. 2004;7:1–27
  18. Chronis AM, Gamble SA, Roberts JE, Pelham WE. Cognitive-behavioral depression treatment for mothers of children with attention-deficit/hyperactivity disorder. Behavior Therapy. 2006;37:143–158
  19. Ciccone, P.E., Starr, H.L., Coleman, J.J., Mrazik, T., DuPont, R., & Bensinger, P.B. (2007, May). OROS MPH: A methylphenidate with a low potential for abuse. Poster session presented at the annual meeting of the American Psychiatric Association, San Diego, CA.
  20. Collett BR, Ohan JL, Myers KM. Ten-year review of rating scales. V: Scales assessing attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2003;42:1015–1037
  21. Faraone SV, Biederman J, Spencer TJ, Aleardi M. Comparing the efficacy of medications for ADHD using meta-analysis. Medscape General Medicine. 2006;8:4
  22. Faraone SV, Biederman J, Zimmerman B. An analysis of patient adherence to treatment during a 1-year, open-label study of OROS methylphenidate in children with ADHD. Journal of Attention Disorders. 2007;11:157–166
  23. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biological Psychiatry. 2005;57:1313–1323
  24. Flippin R. ADHD and learning disabilities: Educational rights and accommodations. Attitude. 2006, February/March;Retrieved October 16, 2008, from http://www.additudemag.com/adhd/article/959.html
  25. Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Archives of Pediatric & Adolescent Medicine. 2007;161:857–864
  26. Gau SS, Shen HY, Chou MC, Tang CS, Chiu YN, Gau CS. Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. Journal of Child and Adolescent Psychopharmacology. 2006;16:286–297
  27. Goldenring JM, Cohen E. Getting into adolescent heads. Contemporary Pediatrics. 1988;5:75–90
  28. Goldenring JM, Rosen DS. Getting into adolescent heads: An essential update. Contemporary Pediatrics. 2004;21:64–90
  29. Greenhill LL, Pliszka S, Dulkan MK. Workgroup on Quality Issues. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the American Academy of Child and Adolescent Psychiatry. 2002;41(Suppl. 2):26S–49S
  30. Guevara JP, Feudtner C, Romer D, Power T, Eiraldi R, Nihtianova S, et al. Fragmented care for inner-city minority children with attention-deficit/hyperactivity disorder. Pediatrics. 2005;116:e512–e517
  31. Harpin VA. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Archives of Disease in Childhood. 2005;90(Suppl. 1):i2–i7
  32. Hazell P. Pharmacological management of attention-deficit hyperactivity disorder in adolescents: Special considerations. CNS Drugs. 2007;21:37–46
  33. Hillemeier MM, Foster EM, Heinrichs B, Heier B Conduct Problems Prevention Research Group. Racial differences in parental reports of attention-deficit/hyperactivity disorder behaviors. Journal of Developmental and Behavioral Pediatrics. 2007;28:353–361
  34. Hurtig T, Ebeling H, Taanila A, Miettunen J, Smalley SL, McGough JJ, et al. ADHD symptoms and subtypes: Relationship between childhood and adolescent symptoms. Journal of the American Academy of Child & Adolescent Psychiatry. 2007;46:1605–1613
  35. Jellinek MS, Murphy JM, Robinson J, Feins A, Lamb S, Fenton T. Pediatric Symptom Checklist: Screening school-age children for psychosocial dysfunction. Journal of Pediatrics. 1988;112:201–209
  36. Johnston C, Mash EJ. Families of children with attention-deficit/hyperactivity disorder: Review and recommendations for future research. Clinical Child and Family Psychology Review. 2001;4:183–207
  37. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. American Journal of Psychiatry. 2006;163:716–723
  38. Kessler RC, Adler LA, Barkley R, Biederman J, Conners CK, Faraone SV, et al. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: Results from the National Comorbidity Survey Replication. Biological Psychiatry. 2005;57:1442–1451
  39. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry. 2005;62:593–602
  40. Kroutil LA, Van Brunt DL, Herman-Stahl MA, Heller DC, Bray RM, Penne MA. Nonmedical use of prescription stimulants in the United States. Drug and Alcohol Dependence. 2006;84:135–143
  41. Langberg JM, Froehlich TE, Loren REA, Margin JE, Epstein JN. Assessing children with ADHD in primary care settings. Expert Review in Neurotherapeutics. 2008;8:627–641
  42. Luby JL, Heffelfinger A, Koenig-McNaught AL, Brown K, Spitznagel E. The Preschool Feelings Checklist: A brief and sensitive screening measure for depression in young children. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:708–717
  43. Madaan V. Lisdexamfetamine dimesylate for childhood ADHD. Drugs Today. 2008;44:319–324
  44. Manos MJ, Tom-Revzon C, Bukstein OG, Crismon ML. Changes and challenges: Managing ADHD in a fast-paced world. Journal of Managed Care Pharmacy. 2007;13(Suppl. B):S2–S13
  45. Matza LS, Paramore C, Prasad M. A review of the economic burden of ADHD. Cost Effectiveness and Resource Allocation. 2005;3:5
  46. McDonagh MS. Drug class review on pharmacologic treatments for ADHD. Portland, OR: Oregon Health & Science University; 2007;Retrieved October 16, 2008, from http://www.ncbi.nlm.nih.gov/books/bookres.fcgi/adhd/pdfadhd.pdf
  47. Nahlik J. Issues in diagnosis of attention-deficit/hyperactivity disorder in adolescents. Clinical Pediatrics. 2004;43:1–10
  48. Nass RD. Evaluation and assessment issues in the diagnosis of attention deficit hyperactivity disorder. Seminars in Pediatric Neurology. 2005;12:200–216
  49. National Institute of Mental Health . Attention deficit hyperactivity disorder. Bethesda, MD: National Institute of Mental Health; 2008;Retrieved October 16, 2008, from http://www.nimh.nih.gov/health/publications/adhd/complete-publication.shtml
  50. Noe L, Hankin C. Health outcomes of childhood attention-deficit/hyperactivity disorder (ADHD): Health care use and work status of caregivers. Value in Health. 2001;4:140–141
  51. Parasrampuria DA, Schoedel KA, Scheuller R, Silber S, Ciccone P, Gu J, et al. Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users. Journal of Clinical Psychopharmacology. 2007;27:459–467
  52. Pelham WE, Foster EM, Robb JA. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. Journal of Pediatric Psychology. 2007;32:711–727
  53. Pliszka S AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46:894–921
  54. Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, et al. Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Deficit Hyperactivity Disorder The Texas Children's Medication Algorithm Project: Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2006;45:642–657
  55. Prince JB, Jensen PS, Vierhile A. Piecing together the ADHD puzzle: Treatment strategies for attention deficit hyperactivity disorder (ADHD): From childhood to adolescence and through the transition years CME/CE. Medscape. 2006;Retrieved October 16, 2008, from http://www.medscape.com/viewprogram/6043
  56. Rojas NL, Chan E. Old and new controversies in the alternative treatment of attention-deficit hyperactivity disorder. Mental Retardation and Developmental Disabilities Research Reviews. 2005;11:116–130
  57. Rothe EM. Considering cultural diversity in the management of ADHD in Hispanic patients. Journal of the National Medical Association. 2005;97(Suppl.):17S–23S
  58. Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behaviour Research and Therapy. 2005;43:831–842
  59. Sayal K, Goodman R, Ford T. Barriers to the identification of children with attention deficit/hyperactivity disorder. Journal of Child Psychology and Psychiatry and Allied Disciplines. 2006;47:744–750
  60. Smith BH, Barkley RA, Shapiro CJ. Attention deficit hyperactivity disorder. In:  Mash EJ,  Barkley RA editor. Treatment of childhood disorders. New York: Guilford; 2006;p. 65–136
  61. Sonuga-Barke EJ, Daley D, Thompson M. Does maternal ADHD reduce the effectiveness of parent training for preschool children's ADHD?. Journal of the American Academy of Child and Adolescent Psychiatry. 2002;41:696–702
  62. Starr HL. The impact of culture on ADHD. ADHD is an equal-opportunity condition, affecting children from all walks of life. But what role, if any, does ethnicity have on the response to diagnosis and treatment?. Contemporary Pediatrics. 2007;24:38–50
  63. Swanson J. Compliance with stimulants for attention-deficit/hyperactivity disorder: Issues and approaches for improvement. CNS Drugs. 2003;17:117–131
  64. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Archives of General Psychiatry. 1999;56:1073–1086
  65. Thiruchelvam D, Charach A, Schachar RJ. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40:922–928
  66. To, S.E. (2005). Highlights of the attention deficit hyperactivity disorder (ADHD) news media briefing. Medscape Psychiatry & Mental Health. Retrieved October 16, 2008, from http://www.medscape.com/viewarticle/502480_print
  67. U.S. Food and Drug Administration. (2006). March 2006 Pediatric Advisory Committee minutes. Retrieved October 16, 2008, from http://www.fda.gov/ohrms/dockets/ac/06/minutes/2006-4210m_Minutes%20PAC%20March%2022%202006.pdf
  68. Vetter VL, Elia J, Erickson C, Berger S, Blum N, Uzark K, et al. Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation. 2008;117:2407–2423
  69. Weiss M, Murray C. Assessment and management of attention-deficit hyperactivity disorder in adults. Canadian Medical Association Journal. 2003;168:715–722
  70. Wilens TE, Gignac M, Swezey A, Monuteaux MC, Biederman J. Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. Journal of the American Academy of Child and Adolescent Psychiatry. 2006;45:408–414
  71. Wolraich ML, Wibbelsman CJ, Brown TE, Evans SW, Gotlieb EM, Knight JR, et al. Attention-deficit/hyperactivity disorder among adolescents: A review of the diagnosis, treatment, and clinical implications. Pediatrics. 2005;115:1734–1746
  72. Woodard R. The diagnosis and medical treatment of ADHD in children and adolescents in primary care: A practical guide. Pediatric Nursing. 2006;32:363–370

 STATEMENT OF CONFLICT OF INTEREST: Amy Vierhile has received grant/research support from Ovation, Eisai, Shire and is on the McNeil Pediatrics Speakers' Bureau. Adelaide Robb has received grant/research support from Janssen, Otsuka, Bristol-Myers Squibb, and Forest Laboratories, has received consulting fees from Lundbeck and Otsuka, is on the Speakers' Bureau for Bristol-Myers Squibb, Eli Lilly, and McNeil Pediatrics, and is on the Advisory Boards for Eli Lilly and Forest Laboratories. Patricia Ryan-Krause has reported no significant financial relationship with any commercial entity related to this activity. XME reviewer Bob Rhodes hereby states that neither he nor his spouse/life partner have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CE activity of any amount during the past 12 months.

PII: S0891-5245(08)00345-3

doi: 10.1016/j.pedhc.2008.10.009

Journal of Pediatric Health Care
Volume 23, Issue 1, Supplement , Pages S5-S21 , January 2009